SMARCA4 mutations as a biomarker for Non-Small Cell Lung Cancer: Prognostic significance and clinical perspectives
European Journal of Cancer · 2026-11 · 248 · 117549
DOI: 10.1016/j.ejca.2026.117549 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2026-11. Verfasst von A. Verlicchi und 12 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Verlicchi, A., Canale, M., Capelli, L., Chiadini, E., Andrikou, K., Citarella, F., Cravero, P., Gallio, C., Flospergher, M., Petracci, E., Crinò, L., Ulivi, P., & Delmonte, A. (2026). SMARCA4 mutations as a biomarker for Non-Small Cell Lung Cancer: Prognostic significance and clinical perspectives. European Journal of Cancer, 248, 117549. https://doi.org/10.1016/j.ejca.2026.117549
Vancouver
Verlicchi A, Canale M, Capelli L, Chiadini E, Andrikou K, Citarella F, et al. SMARCA4 mutations as a biomarker for Non-Small Cell Lung Cancer: Prognostic significance and clinical perspectives. European Journal of Cancer. 2026;248:117549. doi:10.1016/j.ejca.2026.117549
BibTeX
@article{Verlicchi2026,
author = {Verlicchi, A. and Canale, M. and Capelli, L. and Chiadini, E. and Andrikou, K. and Citarella, F. and Cravero, P. and Gallio, C. and Flospergher, M. and Petracci, E. and Crinò, L. and Ulivi, P. and Delmonte, A.},
title = {SMARCA4 mutations as a biomarker for Non-Small Cell Lung Cancer: Prognostic significance and clinical perspectives},
journal = {European Journal of Cancer},
year = {2026},
volume = {248},
pages = {117549},
doi = {10.1016/j.ejca.2026.117549}
}
EUVIMED